Ponce, Kiarrah Jewelrich S.

HRN: 22-64-32  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/24/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/24/2023
03/02/2023
IV
325mg
Q8Hrs
Intestinal Amoebiasis; UTI
Waiting Final Action 

Indication:  ProphylaxisEmpiricCulture-directed    Type of Infection:  BloodstreamIntra-abdominal    Compliance to guidelines: Non-compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: